ELMS STEVE — SEC Form 4 filings
SEC reporting owner CIK 1250195. 14 Form 4 filings on record with FilingPulse; latest filed 2026-03-09.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-28 to 2026-03-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 25,085 shares, $252,892 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 8 legs across 3 filings — 1,925,621 shares, $17,972,493 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 194,749 shares @ $20.24 ($3,941,720) in ADMA BIOLOGICS, INC., filed 2025-06-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | Director | 8 | 2 legs · 14,000 sh · $217,420 | 8 legs · 1,925,621 sh · $17,972,493 | 28 |
| Marker Therapeutics, Inc. (MRKR) | Director | 3 | 1 leg · 11,085 sh · $35,472 | — | 3 |
| Elevation Oncology, Inc. (ELEV) | Director | 3 | — | — | 7 |
Form 4 filings — ELMS STEVE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-09 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Purchase (P): 7,000 @ $15.67 · Purchase (P): 7,000 @ $15.39 | EDGAR |
| 2026-02-11 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 10,690 @ $0 · Grant/award (A): 17,730 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Marker Therapeutics, Inc. (MRKR) | Grant/award (A): 84,411 (derivative) @ $0 · Grant/award (A): 137,330 (derivative) @ $0 | EDGAR |
| 2025-07-24 | 4 | Elevation Oncology, Inc. (ELEV) | Disposition to issuer (D): 31,238 (derivative) @ $0 · Disposition to issuer (D): 15,619 (derivative) @ $0 · Disposition to issuer (D): 31,238 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Sale (S): 92,941 @ $21.69 · Option exercise (M): 9,000 @ $5.96 · Option exercise (M): 10,000 @ $5 · Option exercise (M): 53,837 @ $3.66 · Option exercise (M): 17,500 @ $4.91 · Option exercise (M): 30,000 @ $3.89 · +17 more | EDGAR |
| 2025-06-09 | 4 | Elevation Oncology, Inc. (ELEV) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 10,889 @ $0 · Grant/award (A): 16,279 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Marker Therapeutics, Inc. (MRKR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | Marker Therapeutics, Inc. (MRKR) | Purchase (P): 11,085 @ $3.20 | EDGAR |
| 2024-12-02 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Option exercise (M): 9,000 @ $10.80 · Option exercise (M): 9,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Elevation Oncology, Inc. (ELEV) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Sale (S): 49,887 @ $6.01 · Sale (S): 411,829 @ $6.08 | EDGAR |
| 2024-03-15 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Sale (S): 407,000 @ $6.21 · Sale (S): 448,276 @ $6.05 · Sale (S): 183,008 @ $6.01 | EDGAR |
| 2024-02-28 | 4 | ADMA BIOLOGICS, INC. (ADMA) | Grant/award (A): 24,040 @ $0 · Grant/award (A): 37,541 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1250195 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →